News

The ‘Do Unto Others’ Malaria Vaccine

See allHide authors and affiliations

Science  14 May 2010:
Vol. 328, Issue 5980, pp. 847-848
DOI: 10.1126/science.328.5980.847

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Progress is accelerating on transmission-blocking vaccines (TBVs), which would use humans to generate antibodies and deliver them to mosquitoes, with the aim of preventing the insects from spreading the disease. A half-dozen TBVs could have a shot at clinical trials sometime in the next 5 years, researchers say. Even so, the scientific and social hurdles remain daunting. Key among them is whether people can be persuaded to get a vaccination that doesn't prevent them from getting sick but instead protects family and neighbors from getting infected. That also raises the bar for an extremely safe vaccine.